To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).
Status:
Suspended
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 non-randomized, open-label study to investigate the efficacy, safety and
tolerability of RVT-1401 in patients with Warm Autoimmune Hemolytic Anemia.